脉络膜黑色素瘤质子束照射后持续性渗出性视网膜脱离的结局
这项回顾性研究评估了脉络膜黑色素瘤接受质子束照射后出现持续性大面积渗出性视网膜脱离的50只眼,比较保守治疗(35例)与手术治疗(15例)的结局,发现两组在最终视力、放射性视网膜病变、新生血管性青光眼和眼球摘除方面无差异,难治性渗出性视网膜脱离是新生血管性青光眼的显著危险因素。
要点
- 脉络膜黑色素瘤伴大面积渗出性视网膜脱离经质子束照射后,保守或手术治疗均可成功处理。
- 保守治疗与手术治疗在最终视力、放射性视网膜病变、新生血管性青光眼和眼球摘除方面无差异。
- 难治性渗出性视网膜脱离是新生血管性青光眼发展的显著危险因素。
核心结论
- 脉络膜黑色素瘤伴大面积渗出性视网膜脱离在质子束放射治疗后可通过保守或手术治疗成功处理。
- 难治性渗出性视网膜脱离是新生血管性青光眼发展的显著危险因素。
研究设计与样本
- 回顾性研究,纳入单中心学术三级中心接受质子束照射的脉络膜黑色素瘤患者,纳入标准为诊断时渗出性视网膜脱离至少3个钟点范围。
- 共50例患者的50只眼,中位年龄51.7岁(范围19.3-78.5岁),中位随访35.1个月(范围6.6-247.9个月)。
主要发现
- 35例患者接受保守治疗(包括观察或眼内类固醇),15例患者因持续性渗出性视网膜脱离在质子束照射后中位7.5个月(范围1.3-117.6个月)接受手术治疗(平坦部玻璃体切除术、视网膜下液引流、眼内激光和硅油填充)。
- 保守治疗与手术治疗在最终视力、放射性视网膜病变、新生血管性青光眼和眼球摘除的结局方面无差异。
- 难治性渗出性视网膜脱离是新生血管性青光眼发展的显著危险因素。
临床怎么用
- 脉络膜黑色素瘤伴大面积渗出性视网膜脱离在质子束放射治疗后可采用保守或手术治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the outcomes of persistent large exudative retinal detachments (ERD) following proton beam irradiation (PBI) for choroidal melanoma. METHODS: A retrospective study evaluated patients with a diagnosis of ERD in the setting of choroidal melanoma treated with PBI at a single academic tertiary center. Inclusion criteria were the presence of an ERD for at least 3 clock hours at the time of melanoma diagnosis. Data collected included tumor features, management, and visual and anatomic outcomes. RESULTS: The study comprised 50 eyes of 50 patients with a median age of 51.7 years (range 19.3 - 78.5 years) and a median follow-up of 35.1 months (range 6.6 - 247.9 months). Thirty-five patients were treated with conservative management, which included observation or intraocular steroids, and 15 patients underwent surgical management with pars plana vitrectomy, drainage of subretinal fluid, endolaser, and silicone oil placement for persistent ERD at a median duration of 7.5 months (range 1.3-117.6 months) following PBI. The study found no difference in outcomes of final visual acuity, radiation retinopathy, neovascular glaucoma, and enucleation between conservative and surgical management. Refractory ERD was found to be a significant risk factor for the development of neovascular glaucoma. CONCLUSION: Choroidal melanoma with a large ERD can be successfully treated with conservative or surgical management after proton beam radiation therapy.
引用
- Steinkerchner MS, Lane AM, Gragoudas ES, et al. Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma. Retina. 2025. PMID: 40068201. doi:10.1097/IAE.0000000000004462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。